When Congress returns from summer recess on Monday, lawmakers will have plenty on their plates, especially the vexing issue of high prescription drug prices. Hill-watchers expect action on legislation from both parties which aim to reduce prices at the pharmacy counter, though there is scant consensus on specific policies.
Most Congressional Democrats believe (and the National Committee agrees) that the Department of Health and Human Services must be allowed to negotiate drug prices with pharmaceutical companies on behalf of Medicare.
